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Analysis for aid effectiveness has become a hot topic of Millennium Development Goal area. While 
many studies seek to evaluate ODA effectiveness at macro-level or micro-level, this paper attempts to 
fill the gap by reproducing the analysis at meso-level. The authors tested aid effectiveness in health 
sector with special reference to eight health indicators. Comparing the effect of the same ‘aid’ on 
various health indicators, we found interesting results that the statistical degree and the significance of 
aid vary in health indicators. 
 






Aid effectiveness has been one of the main research topics for years in the field of 
development studies. On a greater scale, the evidence is controversial that aid promotes 
growth (Burnside and Dollar, 2000; Burnside and Dollar, 2004a; Hansen and Tarp, 2001; 
Dalgaard et al., 2004; Burnside and Dollar, 2004b). On a smaller scale, a number of program 
evaluation reports show its success in development assistance. However, there are few 
studies that evaluate aid effectiveness at the meso-level. This paper aims to fill this gap of 
previous studies. To limit the scope of our research, we analyze the aid effectiveness with 
special reference to health sector which are traditionally believed to perform with very low 
improvements. 
Despite the numbers of global humanitarian actions and aid for health improvement, the 
performance of health sector has shown a very slow and little improvement. Given the 
importance and increasing awareness of global health issues, seven among fifteen MDG 
targets are dedicated for the health related matters. This decision surely helped to increase 
Development Assistance for Health Sector (DAH, hereafter)1 massively (see Figure 1). This 
paper attempts to analyze the effectiveness of DAH in the improvement of health 
performances. More specifically, first we look at how we could interpret ODA in health 
sector and its effectiveness; second, whether we look at how different indicators shows 
different outcomes; third, at why the difference occurs; and fourth, consider what are the 
implications the results may have. 
Mishra and Newhouse found that DAH is effective in improving infant mortality rate in 
recipient countries over the period of 1973-2004 (Mishra and Newhouse, 2007). Although 
infant mortality rate is the representative indicator for health performance of a country, we  
                                                          
* This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the 
Korean Government (MEST) (NRF-2008-362-B00015). 
1 For the sake of analysis and data consistency, this paper limits the scope of aid as ODA. Hence, 
Development Assistance for Health (DAH) is also limited for ODA for health sectors.  






































attempted to test it with different health indicators. The reason is that the DAH has various 
components within itself (see figure 2). Therefore, we brought seven other health indicators 
into our research; Child mortality rate, Maternal mortality rate, Tuberculosis incidence, 
Tuberculosis death rate, Tuberculosis treatment success rate, Malaria case reported, and 
Malaria caused death reported. It is to see whether aid effectiveness is consistent throughout 






Figure 1. Trends in DAH and Millennium Development Goal
Figure 2. Composition of DAH (average 2004~08) 
Data source: Aid Data 
Data source: OECD CRS 





2. DATA AND METHODOLOGY 
 
The data set for DAH is extracted from OECD CRS and Aid Data2 (Findley et al., 2010). 
DAH per capita is used for the aid variables. The results do not change between the two data 
sets. We ran regressions by each code and combination of codes related to health sector; 
Code 120, health, code 130 population policies and reproductive health, and code 140, water 
and sanitation. Each code of 120,130,140; sum of 120 and 130; sum of 120, 130, and 140 are 
all tested. In case of Malaria and TB indicators, more specified aid amount targeted for 
Malaria (code 12262) and TB (code 12263) are also tested. Aid disbursement may have 
given truer estimation but it is not reported in this paper for two reasons. First, there is high 
correlation between aid disbursement and commitment data. Second, it is available only for a 
small number of recipients and limited time period. Therefore, we used commitment data for 
statistical purpose. Health indicators are adopted from many sources, including WDI, WHO, 
UNDP, and IHME. Infant Mortality Rate, Child Mortality Rate, Maternal Mortality Rate (per 
1,000 person), Malaria case reported (absolute number), Malaria caused death reported 
(absolute number), Tuberculosis incidence rate (per 100,000 persons), TB caused death rate 
(per 100,000 persons), and TB success rate (% of reported case) with period from 1990 to 
2008 over approximately 150 recipient countries. Two limitations lied here with the data set. 
First, a longer period from the  1970s would allow truer estimation by using more techniques 
of regression analysis. However, we allowed only from the 1990s where TB and Malaria 
data comes available. Second, the number of recipient countries is around 150 countries in 
Infant mortality rates but much less is reported for TB and Malaria. Assuming that the data is 
either not reported (missing value) or the country is free from the disease, we took five-year 
averages for all the indicators and DAH in order to neutralize the temporal variations.  
Below is the bench mark equation (1). Health performance of period t in country i is 
defined as Hit. Hit is the produced result from the sum of effects of health performance of 
previous period (t-1); amount of aid committed to the recipient in previous period (t-1) again 
in order to see the effect of aid needs a time lag; initial GDP of the given period as economic 
proxy; HIV rates of the period as health proxy and also because it has significant influence 
on health performance; and population as demographic proxy; country fixed effect and time 
fixed effects used. Depending on the indicators, additional controls (AC) are used such as 
fertility rate, distribution of insecticide treated nets (ITN), shares of agricultural area.3  
 
lnHit = lnHit-1 + lnAidit-1 + lniGDPit + lnHIVit + lnPopit + (Ui) + Vt +(A) + εit  
lnHit - lnHit-1 = lnAidit-1 + lniGDPit + lnHIVit + lnPopit + (Ui) + Vt + (A) + εit  
 
Equation (2) is simply moving Hit-1 from right hand to left hand side since health 
                                                          
2 The Aid Data is easier to manage in the extraction process according to the purpose codes. In this 
paper, both CRS and Aid data are used for DAH description and trends; and only CRS purpose code is 
reported for regression in this paper. The regression results from Aid Data does not change those from 
CRS in its signs or the significance level. 
3  We tried to include and test as many additional control variables as possible but the data was 
insufficient to run a proper regression. Additional controls of ITN distribution and share of 
agricultural area turned out to be insignificant. We reported only fertility rate that is consistent and the 
results that are significant. 
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performance of given period is mostly explained by the performance of the previous period 
in equation (1). We used simple OLS estimation with fixed effects, and additional controls. 
Time fixed effect Vt is used in order to control universal time trends and temporal variations. 
For example, if there is a universal disease for a certain year, then it will bias the results if 
time fixed effects is not included. Country fixed effect Ui is also tested but the model losses 
explanatory power due to limited data period after controlling country specific variations in 
equation (2). For example, it will control country specific events like war or region specific 
diseases. Also, we need to control the effect of overall improvement of the country. It could 
be partly influenced by the total ODA inflow into a country. Using country fixed effect is 
used in order to control these factors. We have tested with the variable of total ODA inflow, 
however, not reported in this paper because it has partial correlation with GDP per Capita 





3.1. Infant Mortality Rate (IMR) 
 
Infant mortality rate is the number of death of infant under one-year old per 1000 live 
births. IMR average in 1950-55 was 152, which dropped down to 52 in 2000-2005 average. 
Infant mortality rates have significantly declined today except in LDCs. World IMR is 49.4 
according to the UN in 2006 being Angola with IMR 180, the highest rate. IMR 
improvement usually follows after living standard and economic development of one’s 
country. Therefore, it has been the most common proxy for health performance or living 
standard in development and economic literatures. Similar index to IMR, we brought Child 
Mortality Rate (CMR) and Maternal Mortality Rate (MMR) for comparison. CMR is the 
number of death of infant under five. It is considered to be more complicated to control than 
IMR, because one’s health care in congenital and neonatal stage can significantly influence 
one’s health performance when they grow. MMR is the number of maternal deaths per 1,000 
women of reproductive age in the population (generally defined as 15–44 years of age). 
Improvements in the MMR is again much more complicated than CMR. Simply put, when a 
mother is not healthy or malnourished when she is younger, it is harder for her to become 
healthier when she becomes an adult especially when she conceives a child. As Mishra and 
Newhouse found that aid was effective in the improvement of the IMR, we expected the 
similar results for CMR and MMR but possibly to lesser degree.  
If our hypothesis is correct, the sign of the coefficient of aid in IMR, CMR and MMR 
should be negative and significant. Table 1 shows the regression results for IMR, CMR and 
MMR compared which supports our hypothesis. Across all mortality rates above, the 
coefficient of lagged log of aid per capita has a negative sign with 1% significance level. It 
means more aid is likely to reduce mortality rates. Time fixed effect does not change signs or 
significance of aid but reduces its magnitude by negligible amount. In model (2) of IMR, aid 
effectiveness still marginally significant at 5% level. Additional control does not affect the 
results. With the same controls, the coefficient of aid for CMR is also negative and 
significant at 1% level. The coefficient of aid in MMR is also negative but marginally 
significant compared to IMR or CMR. The above result suggests that doubling the current 
level of aid per capita may reduce IMR by at most 1.38%; CMR by 1.45%; and MMR by 
1.79%. It is still encouraging although the coefficients of the mortality rates are small in its  




Note: IMR: infant mortality rate, CMR: Child mortality rate, MMR: maternal mortality rate, FE: time 
fixed effect, ~d: lnHit-lnHit-1, AC: additional control, Parenthesis is t-value, * is significant at 





3.2. Malaria    
 
We chose to look into Malaria and compare it with mortality rates. Malaria is an 
important cause of death and illness especially in tropical countries and has not been 
controlled very effectively. Malaria control requires an integrated approach, including 
prevention (primarily vector control) and prompt treatment with effective anti-malaria drugs. 
I used both Malaria incidence and Malaria caused death. In 2008, there were an estimated 
243 million cases of malaria worldwide. The majority of cases were in the African region 
(85%), followed by the South-East Asia region (10%) and the Eastern Mediterranean region 
(4%). Malaria accounted for an estimated 863,000 deaths in 2008, of which 89% were in the 
African region, followed by the Eastern Mediterranean (6%) and South-East Asia (5%) 
regions. The majority (85%) of deaths were in children under five years of age (WHO, 
2010b). 
Unlike mortality rates, aid turned out to be ineffective on Malaria control. The results are 
consistent across all specifications for both Malaria incidence and Malaria caused death, with 
fixed effects and additional control or without (see table 2). We went for another experiment 
for Malaria to see direct effect of aid targeting Malaria control. We extracted code 12262, aid 
assigned only for Malaria control from total DAH to see if it does have effects indeed. It also 
did not. Two implications can be drawn here. First, more money is needed for Malaria 
control. It is always controversial how much will be ‘enough’ to bring effective control but 
the discussion is beyond the scope of our research. Second, control of Malaria itself has very 
complicated nature, which we are more inclined to for an interpretation of aid ineffectiveness 
of Malaria reduction. Malaria is a disease transmitted through parasites called plasmodia 
reside in malaria mosquito. Men are the host, mosquito is the vector and plasmodium is the 
agent. Consequently, Malaria control needs to be conducted though all three-way integrated 
approach – the host, the vector, and the agent control. As for the host control, there is 
prevention and treatment mechanism. The first intervention as prevention, insecticide-treated  
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Note: MalC: Malaria case incidence, MalD: Malaria caused death, FE: time fixed effect, ~d: lnHit-lnHit-
1, AC: additional control, Parenthesis is t-value, * is significant at 10% level, ** is significant at 
5% level, *** is significant at 1% level 
 
 
bed-nets (ITN), mosquito repellent, and indoor residual spraying (IRS) can be useful to 
protect men from mosquito bites. Meanwhile, there is no guarantee purchase and the 
distribution of ITN and IRS are correlated to the use of them and thus effective as malaria 
control. In many cases in malaria risk area, people are not very aware or educated of the 
necessity and the proper use of nets; aid spent for the purchase and distribution of ITN is 
often wasted. This is probably why additional control of distribution of ITN yields no 
significant effects.4 Besides the prevention of mosquito bites, early diagnosis and treatment 
is also important to reduce malaria caused death rate. On the treatment side, it is very 
complicated as well. Malaria is caused by infection of red blood cells with protozoan 
parasites of the genus Plasmodium. The parasites are inoculated into the human host by a 
feeding female anopheline mosquitos. The four Plasmodium species that infect humans are P. 
falciparum, P. vivax, P. ovale and P. malariae. In addition, human infections with the 
monkey malaria parasite, P. knowlesi, have also been increasingly reported. Increasingly also 
some types of malaria including P. vivax is resistant to Cloroquine. So it is essential to 
diagnose the types and to use the correct treatment methods. It is also crucial for Malaria 
infected patients to take anti-malaria drugs such as Chloroquine or Primaquine promptly (for 
some cases, the critical time line is 48 hours). Quick diagnosis kit and sufficient distribution 
of anti-malaria drug are useful in this respect. 
However, most of Malaria prevalent countries are concentrated in sub-Saharan areas 
which are mostly LDCs. Naturally; they do not have sufficient medical system for prompt 
treatment and early diagnosis. The second intervention is to control mosquito. Malaria is 
often called as ‘disease of the poor’ because Malaria mosquito cannot breed or live in 
contaminated water. Since it lives only in clean water, mostly malaria occurs in rural area 
with large agricultural environment. Therefore, in order to control the vector, prevention of 
water-logging and killing larvae is required. We also used the share of agricultural area as 
                                                          
4 Therefore, not reported in the paper. 




additional variable, but it did not have significant effect. The reason may be that not all the 
countries with large agricultural area are not in malaria risk area, to name one the 
Netherlands. Third intervention is to control parasite which is not very easy. Besides, there’s 
no effective vaccine for Malaria developed so far. Such embedded characteristic of malaria 
complicated the control mechanism, and is to be blamed for aid ineffectiveness regarding 
Malaria control.  
 
3.3. Tuberculosis(TB) incidence, TB caused death, TB success rate 
 
The estimates of the global burden of disease caused by TB in 2009 are as follows: 9.4 
million incident cases (range 8.9 million–9.9 million), 14 million prevalent cases (range, 12 
million–16 million), 1.3 million deaths among HIV-negative people (range, 1.2 million–1.5 
million) and 0.38 million deaths among HIV-positive people (range, 0.32 million–0.45 
million). Most cases were in the Southeast Asia (35%), African (30%) and Western Pacific 
regions (20%) to give a brief overview (WHO, 2010a). Being a good reason that TB is also a 
concern in global health issues, we also examined the case of Tuberculosis. It provided a 
good comparison and evidence from what we could observe difference between mortality 
rates and malaria indicators. There were three indicators regarding Tuberculosis which we 
expected to find some clues on the differences among the indicators.  
Same models and specifications are used for three indicators of TB: TB incidence (per 
100,000), TB caused death (per 100,000), and TB success rate (% of reported case). Table 3 
summarizes the regression results. Interestingly, the coefficient for aid with respect to TB 
success rate is insignificant while TB incidence and TB death are. Fixed effects and 
additional control does not change the results. Comparing the three indicators of TB, it 
shows similar pictures that we observe between mortality rates and malaria we observed. TB 
case incidence and TB caused death is relatively easier to control than TB success rates. 
Therefore, the regression suggests that aid is effective in TB case incidence and TB caused 
death but not in TB treatment success rates. 
 
Note: TBC: Tuberculosis incidence, TBD: Tuberculosis caused death, TBS: Tuberculosis treatment 
success rate, FE: time fixed effect, AC: additional control. ~d: lnHit-lnHit-1, Parenthesis is t-value, 
* is significant at 10% level, ** is significant at 5% level, *** is significant at 1% level 
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This can be interpreted that TB incidence and TB caused death tends to decrease as 
overall health environment of the country is improving (by aid for noticeable portion). It 
suggests that doubling the current level of aid per capita reduces TB incidence and TB 
caused death by 1.93% and 2.47% respectively. However, the effectiveness of aid has not 
been significant in improving TB treatment success rates. When a patient is diagnosed as TB, 
consumption of drug for 3-4 weeks infectiousness of TB almost disappears. However, the 
patient must take drugs continuously without cession, everyday, until TB is proved to be 
successfully terminated, which varies from several months to years depending on patients 
and significance of the disease. If the patient skips or stops taking drug, he or she will have 
to restart the treatment from the beginning and will also have greater chance to bear 
resistance to the drug.  
TB success rate is very low in LDCs. Assuming the case of the LDC again, the hurdles of 
TB control lies in every stage of intervention; i) a patient come to the medical center when 
the symptom got really aggravated which is more costly; ii) either it is too far and too costly 
to travel to medical centers where diagnosis, treatment and the provision of anti-TB drug are 
available; iii) worse is the case if the patient needs to pay for the drug. He/she will be very 
much likely to stop the medication when he/she feels better due to financial reason. Or even 
in some case, the patients sell residual drugs to earn money for food or family living 
expenses; iv) rarely the case is local provision of drug ceased for somehow reasons, and 
patients can’t continue medication. In sum, patients’ awareness of the treatment of the 
disease and willingness for complete success to get well are important to control the disease 
together with accessibility to the diagnosis and medication. Besides this, increasing difficulty 
to TB success rate is Multi-drug Resistance (MDR) or Extensive drug Resistance (XDR) 
partly caused by above mentioned problems.  
Above results across eight health indicators is partly related to current debates on donor’s 
coordination and the improvement of health systems. Malaria is a high burden but neglected 
disease (Shiffman, 2006). Tuberculosis has improved but still high burden in LDCs. The 
Global Fund for Tuberculosis, AIDS, and Malaria (GF) was born in response to that needs. It 
is promising that aid for such disease is rapidly increasing. However, what matters in an 
equally important way is the system of allocation and implementation. DAH injected in 
recipient countries somehow improved general health performances of the country though it 
has been very marginal – where we see aid being effective in more general indicators like 
IMR. On the other hand, the ineffectiveness of aid in more specific issues like Malaria or TB 
treatment success rate can be interpreted as aid being uncoordinated or having not good 
enough strategies in controlling the disease. If the disease has a complicated mechanism to 
control which we cannot do anything to change it, what we can do is design the 
implementation and programs to be more specific to break the chains of complexity. In case 
of Malaria, for example, distribution of ITN is better to be followed by sufficient education 
for basic knowledge of malaria for the population in malaria risk area – such as how to 
prevent from biting, why it is important to use ITN and IRS, or finding out and fill in any 
water logging in their neighboring area. In case of TB success rate, directly observed 
treatment (DOT) 5  has been conventional wisdom of TB treatment. However, DOT is 
insufficient. Introducing some incentive structure for patients on the termination of disease 
and for health practitioner on patients’ performance seems to be more useful than only using 
                                                          
5 Patients’ taking drugs on site where medical staff observes. 




DOT, together with more accessibility of treatment sites and drugs.6 We leave the job of 
finding out what strategy is more efficient or how to design the implementation to studies of 
program/impact evaluation and experts/practitioners of each area.  
 
 
4. ROBUSTNESS CHECK AND LIMITS 
 
We ran regression with aid per GDP instead of aid per capita, and the result was the same 
with very marginal changes in coefficients. DAH is also disaggregated for further 
verification by each code of 120, health, 130, population policies and reproductive health, 
and 140, water and sanitation. Below is a summary of regression results run by each codes.   
Our expectation for aid code 120 still effective was for IMR, TB case incidence and TB 
caused death. Aid code 120 in CMR and in MMR was insignificant, which can be interpreted 
due to their more complexity compared to IMR. Results met our expectations except with aid 
effectiveness of code 120 being marginal in TB caused death. Malaria did not have aid 
effectiveness in our previous regressions and so as in the regressions by each code as also 
expected. The results also proves that code 130 and 140 by itself do not have much effect on 
health performances because they are relatively indirect input. Neither the sum of 130 and 
140 does in accordance. We also disaggregate aid into direct input factors for a test. Aid for 
TB (code 12263) and aid for Malaria (code 12262) in corresponding indicators, however, 
turned out to be insignificant. Part of the reasons was already explained in the previous 
sections on TB and Malaria. In the technical side of the study, using GMM or IV controls 
could have been a must-check; however, the observation has insufficient number of periods 
to do so. The results presented here are to get some insights from what we have in our hands 















                                                          
6 In some cases, medical practitioner gets deposits from patients and gives it back when the patient is 
diagnosed to be successfully cured. In some other cases, health practitioner gets incentives as the 
patient appear at the hospital when he/she is told to do so and take medication as it is instructed. When 
local health staff is rewarded with incentives, they try very hard to make sure the patients understand 
and do appear next time for the succession of treatment. Both had increased the treatment ratio 
significantly. However, such program has not been internationally recognized. (the author’s personal 
observation in Bangladesh)  
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For all the health indicators used in this study, additional controls do not change the 
results; fertility rates for all indicators did not change the results; distribution rates of ITN 
and agricultural area for Malaria turned out to be insignificant. One of the hot-topics today in 
DAH is improving health system in order to increase effectiveness of health aid. 
Unfortunately, we could not find a data on health system of sufficient number of countries 
and periods. It is also valuable research to include variables of MDR and XDR in the 
empirical analysis. Those remain a good challenge of future research when the data become 
more available.  
 
 
5. IMPLICATION AND DISCUSSION 
 
The effectiveness of DAH has been in question for years. This paper analyzed DAH to 
see whether it has been effective or not, in which area (indicators/targets), and why? Our 
general hypothesis was that aid may show effectiveness for most representative health 
indicators rather than indicators for more specifically targeted disease or those embedded 
with complicated control mechanism. The authors analyzed aid effectiveness using the same 
‘aid’ comparing eight health indicators.  
Figure 3 is a diagram of DAH effectiveness and the nature of health indicators in 
summary of regression results – shaded area yields aid effectiveness; intuitively, DAH is 
expected be effective in category area (1); health indicators which are more general than 
specific or targeted disease that lie in category (2), DAH is likely to be effective (IMR, CMR, 
and MMR); Health indicators that are more specific but relatively easier to control that lie in 
category (3), DAH is also likely to be effective (TB incidence and TB caused death); finally, 
as for the health indicators with specific/targeted disease with complicated mechanism that 
lie in non-shaded area category (4), DAH is likely to be ineffective (Malaria incidence, 
Malaria caused death, TB treatment success rate).  
 
 






















Analysis of the aid effectiveness at macro-level, with regard to growth, is too broad while 
program evaluation seems too narrow to measure overall aid effectiveness. Even in the 
health sector analysis, we see overall improvement of the sector itself, and have not shown 
the consistent. We believed that the meso-level approach will give us better understanding of 
the sector effectiveness of aid. The comparison amongst eight indicators shows interesting 
results that even in the health sector, we may need to break it down to further level. Our 
analysis on these few critical specific health indicators exhibits a picture that is similar to 
macro and micro paradox. 
Among many, we chose the health sector which has been considered as very difficult area 
to achieve tangible improvements. We adopted eight health indicators to measure and 
compare the DAH effectiveness and found the followings; DAH has been effective in 
general improvement of health sectors though coefficient is relatively small. However, it has 
not been so in more specific disease controls. The outcome depends on the nature of that 
specific disease control. Although we are well aware of major limitation of our dataset being 
inconsistent and complete dropping of the big number of samples, this analysis could at least 
open up new area of discussion in this field. We expect to conduct a similar study in the 
future when the data for these health indicators give us longer time period and wider 
availability.  
How to improve the performances is mostly by increasing the effectiveness of each 
projects and aid programs, of course. Indeed, it is in the field of program evaluation to figure 
out the design and strategies for more effective aid. Our study does not go into details but 
suggests that the effectiveness of the same aid can also differ across different indicators even 
within the same sectors and with same aid.  
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